Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y015992 | — |
No symptoms or side effects reported; Physician called to report a T/E on PROQUAD and one dose was administered to a patient today, 3/3/2025. No symptoms or side effects reported.; This spontaneous report has been received from a physician regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 03-MAR-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Injection, at a dose of 0.5 mL, administered as prophylaxis (lot number reported as Y015992, which has been verified as valid, expiration date reported and validated as 23-MAR-2026), with sterile diluent (BAXTER STERILE DILUENT). The administered dose was exposed to a temperature excursion of 40 Fahrenheit degrees (F) for 1800 hours. No symptoms or side effects reported.; Sender's Comments: Priority : 5 , Is case serious : No , MNSC number : 02762610-02762603 , CLIC number : , ESTAR number : , IRMS number : 500UW00000V5aViYAJ|03032025230058|1370 , Central date : 2025-03-04 , Classification : DMC, Attachment description : NSC Call , Safety case number : , MNSC case number : 02762610 , MNSC interaction number : 02762603 , Integration log UniqueID : 500UW00000V5aViYAJ|03032025230058|1370 , Service cloud CaseID : 500UW00000V5aViYAJ
Sterile diluent